Related Experiment Video
Updated: Feb 6, 2026

Dietary Supplementation of Polyunsaturated Fatty Acids in Caenorhabditis elegans
Published on: November 29, 2013
Effect of Chlorogenic Acid Supplementation in MPTP-Intoxicated Mouse
Saumitra S Singh1, Sachchida N Rai1, Hareram Birla1
1Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, India.
Abstract:
Oxidative stress and neuroinflammation play a key role in dopaminergic (DA) neuronal degeneration, which results in the hindrance of normal ongoing biological processes in the case of Parkinson's disease. As shown in several studies, on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration, different behavioral parameters have suggested motor impairment and damage of antioxidant defence. Thus, some specific biological molecules found in medicinal plants can be used to inhibit the DA neuronal degeneration through their antioxidant and anti-inflammatory activities. With this objective, we studied chlorogenic acid (CGA), a naturally occurring polyphenolic compound, for its antioxidant and anti-inflammatory properties in MPTP-intoxicated mice. We observed significant reoccurrence of motor coordination and antioxidant defence on CGA supplementation, which has been in contrast with MPTP-injected mice. Moreover, in the case of CGA-treated mice, the enhanced expression of tyrosine hydroxylase (TH) within the nigrostriatal region has supported its beneficial effect. The activation of glial cells and oxidative stress levels were also estimated using inducible nitric oxide synthase (iNOS) and glial fibrillary acidic protein (GFAP) immunoreactivity within substantia nigra (SN) and striatum of MPTP-injected mice. Administration of CGA has prevented the neuroinflammation in SN by regulating the nuclear factor-κB expression in the MPTP-induced group. The significant release of certain pro-inflammatory mediators such as tumor necrosis factor-α and interleukin (IL)-1β has also been inhibited by CGA with the enhanced expression of anti-inflammatory cytokine IL-10. Moreover, reduced GFAP staining within the nigrostriatal region has supported the fact that CGA has significantly helped in the attenuation of astrocyte activation. Hence, our study has shown that CGA supplementation shows its therapeutic ability by reducing the oxidative stress and neuroinflammation in MPTP-intoxicated mice.
Insights
Chlorogenic acid (CGA) supplementation improved motor function and antioxidant defense in mice with Parkinson's disease-like symptoms. CGA reduced neuroinflammation and oxidative stress, demonstrating its therapeutic potential.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Parkinson's disease involves dopaminergic (DA) neuronal degeneration driven by oxidative stress and neuroinflammation.
- 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) intoxication models Parkinson's disease, causing motor impairment and reduced antioxidant defenses.
- Medicinal plant compounds with antioxidant and anti-inflammatory properties may offer neuroprotection.
Purpose of the Study:
- To investigate the neuroprotective effects of chlorogenic acid (CGA) against MPTP-induced neurodegeneration in mice.
- To evaluate CGA's antioxidant and anti-inflammatory properties in a Parkinson's disease model.
- To assess CGA's impact on motor function, DA neuronal health, and inflammatory markers.
Main Methods:
- MPTP intoxication model in mice to induce Parkinson's-like pathology.
- Administration of chlorogenic acid (CGA) to assess its therapeutic effects.
- Behavioral tests for motor coordination, immunohistochemistry for tyrosine hydroxylase (TH), glial fibrillary acidic protein (GFAP), and inducible nitric oxide synthase (iNOS).
- Measurement of pro-inflammatory cytokines (TNF-α, IL-1β) and anti-inflammatory cytokine (IL-10), and nuclear factor-κB (NF-κB) expression.
Main Results:
- CGA supplementation restored motor coordination and antioxidant defense in MPTP-intoxicated mice.
- CGA enhanced tyrosine hydroxylase (TH) expression in the nigrostriatal region, indicating DA neuron protection.
- CGA significantly reduced neuroinflammation by decreasing glial cell activation (GFAP, iNOS) and inhibiting NF-κB signaling.
- CGA modulated cytokine profiles, reducing pro-inflammatory mediators (TNF-α, IL-1β) and increasing anti-inflammatory IL-10.
Conclusions:
- Chlorogenic acid (CGA) exhibits significant therapeutic potential against Parkinson's disease.
- CGA alleviates neuroinflammation and oxidative stress in MPTP-induced neurodegeneration.
- CGA supplementation offers a promising natural strategy for managing Parkinson's disease symptoms and progression.
Related Concept Videos
Amino acids
Polyprotic Acids
Mixtures of Acids
A Mixture of a Strong Acid and a Weak Acid
In a mixture of a strong acid and a weak acid, the strong acid dissociates completely and becomes a source of almost all the hydronium ions...
Nucleic Acids
DNA and RNA
The two main types of nucleic acids are deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). DNA is the genetic material in all living organisms, ranging from single-celled bacteria to multicellular mammals. It is in the nucleus of eukaryotes and in the organelles, chloroplasts, and mitochondria. In prokaryotes,...
Nucleic acids
DNA and RNA
The two main types of nucleic acids are deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). DNA is the genetic material in all living organisms, ranging from single-celled bacteria to multicellular mammals. It is in the nucleus of eukaryotes and in the organelles, chloroplasts, and mitochondria. In prokaryotes,...
Acidity of Carboxylic Acids

